FDA Drug Safety Communication: Serious allergic reactions reported with the use of Saphris (asenapine maleate)
Links shared publicly online about this topic.
- 29total visits
FDA Drug Safety Communication: Serious allergic reactions reported with the use of Saphris (asenapine maleate)
fda.gov —
View full resource at fda.gov
Tags: Allergies, Antipsychotic Medication, Diet and Nutrition, Drug, FDA, Safety
Most Recently Shared on September 1, 2011 at 6:39 pm By:
FDA Drug Safety Communication: Serious allergic reactions reported with use of Saphris (asenapine maleate): http://t.co/ZGivqxI via @AddThis
FDA Drug Safety Podcast for Healthcare Professionals: Serious allergic reactions reported with the use of Saphris (asenapine maleate)
fda.gov — “FDA Drug Safety Podcast for Healthcare Professionals: Serious allergic reactions reported with the use of Saphris (asenapine maleate)” View full resource at fda.gov
Most Recently Shared on September 2, 2011 at 2:57 pm By:
RT @fda_drug_info: Drug Safety Podcast:Serious allergic reactions reported with the use of Saphris. http://t.co/AKdbvNt
FDA reports serious allergic reactions with Saphris use - - Drug Topics
drugtopics.modernmedicine.com — “FDA has issued a Safety Announcement warning that serious allergic reactions have been reported with the use of the antipsychotic medication asenapine maleate (Saphris).” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on September 1, 2011 at 10:51 pm By:
Peter H Brown Doctor and Psychologist
FDA reports serious allergic reactions with Saphris use http://t.co/hnKRMVm #bipolar
Advertisement
